Robert Glatter, MD, an emergency physician at Lenox Hill Hospital in New York City and assistant professor at Zucker School of Medicine, told Healthline that these findings support the idea that some patients may have partial biologic resistance to incretin-based therapies. He added that genetics explains only part of the treatment differences and that routine pharmacogenomic screening is not yet ready for widespread clinical use. The same article noted that this PAM research looked at bloodsugar control, not weight loss, and GLP1 drugs are typically prescribed at higher doses for obesity than for diabetes
The reviews read as authentic overall, even if the Trustpilot comments seemed a little too glowing to us
Additionally, the psychological adjustment to a thinner body image and changed eating habits may trigger anxiety in some individuals, particularly those with a history of disordered eating or mood disorders
May 5, 2026 GLP-2 TZ and GLP-3 RT differ in receptor count and downstream pharmacology
Telogen effluvium happens when major life events knock hairs natural cycles out of whack and can be triggered by illness, surgery, hormonal shifts, stress, nutritional deficiency or rapid weight loss